Role of Ruxolitinib in Steroid-Refractory Graft versus Host Disease in Patients Undergoing Allogeneic Stem Cell Transplant.
J Coll Physicians Surg Pak
; 32(9): 1225-1227, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-36089728
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Graft vs Host Disease
Type of study:
Etiology_studies
/
Observational_studies
Limits:
Humans
Language:
En
Journal:
J Coll Physicians Surg Pak
Journal subject:
MEDICINA
Year:
2022
Document type:
Article
Affiliation country:
Pakistan
Country of publication:
Pakistan